Key result
Bone marrow AT2 receptor deficiency increased atherosclerotic lesion area by 51% in apoE-deficient mice compared to wild-type bone marrow.
Bone marrow AT2 receptor deficiency aggravates atherosclerosis development in apoE-deficient mice, likely by impairing macrophage LXRβ-mediated anti-atherogenic actions.
Answers are grounded in this paper and cite their sources.
Suggests bone marrow AT2 receptors protect against atherosclerosis; hypothesis-generating in mice, leaves open human translation.
BACKGROUND: Bone marrow (BM) Angiotensin II (Ang II) type 1 (AT1) receptor plays a crucial role in atherosclerosis development; however, the effect of BM Ang II type 2 (AT2) receptor on atherogenesis remains undefined. METHODS AND RESULTS: We generated BM chimera apoE-deficient (apoE(-/-)) mice whose BM cells were repopulated with AT2-deficient (Agtr2(-/-)) or wild-type (Agtr2(+/+)) cells. After 2 months of a high-cholesterol diet, the atherosclerotic lesion area was significantly increased in the apoE(-/-)/BM-Agtr2(-/-) mice compared with the apoE(-/-)/BM-Agtr2(+/+) mice (51%, P < 0.05), accompanied by an augmented accumulation of lesion macrophages. Although phenotypic polarization in BM-derived macrophages and lipopolysaccharide-induced expression of proinflammatory cytokines in thioglycollate-induced peritoneal macrophages (TGPMs) were not affected by AT2-deficiency, mRNA and protein expression levels of macrophage liver X receptor β (LXRβ) were significantly decreased in Agtr2(-/-) TGPMs compared with Agtr2(+/+) TGPMs. Anti-inflammatory effects of LXR agonist (GW3965) were markedly inhibited in Agtr2(-/-) TGPMs. Furthermore, the expression levels of ATP-binding cassette transporter ABCA1 and CCR7 were much lower in Agtr2(-/-) TGPMs than Agtr2(+/+) TGPMs, accompanied by a significantly reduced cholesterol efflux. CONCLUSIONS: Our findings demonstrate that BM-AT2 deficiency aggravates atherosclerosis, at least in part, by eliminating the anti-atherogenic properties of macrophages elicited by LXRβ activation.
No takes yet. Share an insight, caveat, or question.
Kato et al. (2014) studied Atherosclerosis. Bone marrow AT2 receptor deficiency (Agtr2-/-) vs. Wild-type bone marrow cells (Agtr2+/+) was evaluated on Atherosclerotic lesion area (51% increase, p=< 0.05). Bone marrow AT2 receptor deficiency increased atherosclerotic lesion area by 51% in apoE-deficient mice compared to wild-type bone marrow.
Synapse has enriched 10 related papers. Consider them for comparative context: